NHS to fast-track patients with head and neck cancer into vaccine trial
Posted:
More than 100 patients with advanced head and neck cancer in England will be matched to the trial, running at 15 NHS hospitals over the next year, supported by the NHS’ Cancer Vaccine Launch Pad (CVLP).
The number of doctors and experts that bridge the gap between university research and the NHS – translating discoveries into patient care – is "ageing and shrinking", the Academy of Medical Sciences has warned.
The UK's life sciences industry generated £146.9bn in…
A new machine learning tool developed by researchers at the Queensland Institute of Medical Research Berghofer can help pathologists identify subtle cancer biomarkers in standard tissue samples.
The tool, called STimage, applies spatial analysis to hematoxylin and eosin-stained (H&E) tissue…
Attendees
Sponsors and Exhibitors
Contact us